By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TB Alliance 

40 Wall Street
24th Floor
New York  New York  10005  U.S.A.
Phone: 212-227-7540 Fax: 212-227-7541



Company News
TB Alliance Appoints Dr. Nader Fotouhi, Chief Scientific Officer 5/14/2014 7:29:51 AM
PSI CEO Karl Hofmann Elected President of TB Alliance's Stakeholders Association, Joins Board of Directors 2/25/2013 9:00:06 AM
Sanofi (France) (SAN.PA) Signs Tuberculosis Research Deal With TB Alliance 9/20/2012 7:45:15 AM
TB Alliance Appoints David Greeley, Head of External Affairs 2/7/2012 8:57:31 AM
TB Alliance Release: New Generation of Lifesaving Medicines and Vaccines for the World's Poor Now at Risk 12/7/2011 11:42:11 AM
TB Alliance Release: US Government HIV/AIDS Clinical Trial Sites to Accelerate Completion of Phase III TB Drug Trial 11/15/2011 9:25:42 AM
SCYNEXIS, Inc. and TB Alliance Sign HEOS Software Agreement 6/16/2011 9:05:16 AM
TB Alliance: Lancet Article Highlights Hope in the Tuberculosis Drug Development Pipeline 5/19/2010 9:52:34 AM
TB Alliance and AstraZeneca PLC (AZN) Form Research Collaboration to Fight Tuberculosis 5/4/2010 9:01:47 AM
TB Alliance Appoints Dr. Carlos Morel to Board of Directors 1/14/2010 9:49:57 AM